Alerts will be sent to your verified email
Verify Email
CONCORD
|
Concord Drugs
|
Biofil Chem & Pharma
|
Accretion Pharma.
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
3.38 % | 5.42 % | 72.47 % |
|
5yr average Equity Multiplier
|
1.86 | 2.09 | 5.06 |
|
5yr Average Asset Turnover Ratio
|
0.9 | 0.96 | 1.24 |
|
5yr Avg Net Profit Margin
|
1.88 % | 2.86 % | 11.51 % |
|
Price to Book
|
1.99 | 3.62 | 0.0 |
|
P/E
|
159.32 | 24.25 | 9.65 |
|
5yr Avg Cash Conversion Cycle
|
260.53 Days | 65.55 Days | 108.78 Days |
|
Inventory Days
|
138.17 Days | 25.38 Days | 156.95 Days |
|
Days Receivable
|
144.77 Days | 244.02 Days | 62.93 Days |
|
Days Payable
|
77.93 Days | 179.27 Days | 111.1 Days |
|
5yr Average Interest Coverage Ratio
|
1.8 | 21.93 | 5.99 |
|
5yr Avg ROCE
|
8.9 % | 7.69 % | 55.84 % |
|
5yr Avg Operating Profit Margin
|
9.09 % | 4.5 % | 22.25 % |
|
5 yr average Debt to Equity
|
0.55 | 0.04 | 2.52 |
|
5yr CAGR Net Profit
|
-21.63 % | -10.11 % | 117.34 % |
|
5yr Average Return on Assets
|
1.77 % | 2.72 % | 14.33 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
54.39 % | 46.82 % | 73.51 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
5.39 % | 0.0 | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Concord Drugs
|
Biofil Chem & Pharma
|
Accretion Pharma.
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|